JPWO2024111560A5 - - Google Patents
Info
- Publication number
- JPWO2024111560A5 JPWO2024111560A5 JP2024560149A JP2024560149A JPWO2024111560A5 JP WO2024111560 A5 JPWO2024111560 A5 JP WO2024111560A5 JP 2024560149 A JP2024560149 A JP 2024560149A JP 2024560149 A JP2024560149 A JP 2024560149A JP WO2024111560 A5 JPWO2024111560 A5 JP WO2024111560A5
- Authority
- JP
- Japan
- Prior art keywords
- carbonyl
- indazol
- azetidin
- ethan
- trifluoromethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022185827 | 2022-11-21 | ||
| JP2022185827 | 2022-11-21 | ||
| PCT/JP2023/041679 WO2024111560A1 (ja) | 2022-11-21 | 2023-11-20 | Ｄｄｒ１キナーゼ阻害剤としての化合物および医薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2024111560A1 JPWO2024111560A1 (https=) | 2024-05-30 |
| JPWO2024111560A5 true JPWO2024111560A5 (https=) | 2025-12-09 |
| JP7823226B2 JP7823226B2 (ja) | 2026-03-03 |
Family
ID=91195603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560149A Active JP7823226B2 (ja) | 2022-11-21 | 2023-11-20 | Ｄｄｒ１キナーゼ阻害剤としての化合物および医薬 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP4624465A1 (https=) |
| JP (1) | JP7823226B2 (https=) |
| KR (1) | KR20250109234A (https=) |
| CN (1) | CN120569374A (https=) |
| AU (1) | AU2023386923A1 (https=) |
| CL (1) | CL2025001435A1 (https=) |
| CO (1) | CO2025006877A2 (https=) |
| IL (1) | IL320735A (https=) |
| MX (1) | MX2025005556A (https=) |
| PE (1) | PE20251709A1 (https=) |
| TW (1) | TW202430151A (https=) |
| WO (1) | WO2024111560A1 (https=) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2017A (en) | 1841-03-26 | The graphic co | ||
| IL165863A0 (en) * | 2002-06-24 | 2006-01-15 | Schering Corp | Indole derivatives useful as histamine H3 antagonists |
| DE10337184A1 (de) * | 2003-08-13 | 2005-03-10 | Gruenenthal Gmbh | Substituierte 3-Pyrrolidin-Indol-Derivate |
| EP1965862A2 (en) * | 2005-12-21 | 2008-09-10 | Schering Corporation | Combination of an h3 antagonist/inverse agonist and an appetite suppressant |
| SMT201800070T1 (it) | 2012-12-19 | 2018-03-08 | Celgene Quanticel Res Inc | Inibiorti di istone demetilasi |
| US9199945B2 (en) | 2013-06-21 | 2015-12-01 | MyoKardia, Inc. | Cycloalkyl-substituted pyrimidinedione compounds |
| US9598419B1 (en) | 2014-06-24 | 2017-03-21 | Universite De Montreal | Imidazotriazine and imidazodiazine compounds |
| CN108276388B (zh) * | 2017-03-10 | 2020-01-14 | 成都医学院 | 1h-吲哚类衍生物及其用途 |
| KR102297587B1 (ko) * | 2018-08-07 | 2021-09-06 | 재단법인 대구경북첨단의료산업진흥재단 | 치환된 n-헤테로아릴 유도체, 이의 제조방법 및 이를 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물 |
| KR102886315B1 (ko) | 2018-12-21 | 2025-11-14 | 닛산 가가쿠 가부시키가이샤 | 고분자 및 금속미립자를 포함하는 무전해도금하지제 |
| WO2020210642A1 (en) * | 2019-04-10 | 2020-10-15 | Camp4 Therapeutics Corporation | Methods and compositions for treating urea cycle disorders |
| US12403137B2 (en) | 2019-10-28 | 2025-09-02 | Tango Therapeutics, Inc. | Compounds and methods of use |
| WO2022051569A1 (en) * | 2020-09-04 | 2022-03-10 | Ikena Oncology, Inc. | Substituted 3-piperidinyl-pyrrolo[2,3-b]pyridines and related compounds and their use in treating medical conditions |
| WO2022140290A1 (en) * | 2020-12-21 | 2022-06-30 | Cytokinetics, Inc. | Pyrazole derivatives useful as nampt modulators |
-
2023
- 2023-11-20 TW TW112144826A patent/TW202430151A/zh unknown
- 2023-11-20 CN CN202380091730.4A patent/CN120569374A/zh active Pending
- 2023-11-20 PE PE2025001026A patent/PE20251709A1/es unknown
- 2023-11-20 KR KR1020257020743A patent/KR20250109234A/ko active Pending
- 2023-11-20 AU AU2023386923A patent/AU2023386923A1/en active Pending
- 2023-11-20 EP EP23894566.1A patent/EP4624465A1/en active Pending
- 2023-11-20 WO PCT/JP2023/041679 patent/WO2024111560A1/ja not_active Ceased
- 2023-11-20 JP JP2024560149A patent/JP7823226B2/ja active Active
-
2025
- 2025-05-06 IL IL320735A patent/IL320735A/en unknown
- 2025-05-13 MX MX2025005556A patent/MX2025005556A/es unknown
- 2025-05-15 CL CL2025001435A patent/CL2025001435A1/es unknown
- 2025-05-26 CO CONC2025/0006877A patent/CO2025006877A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI820622B (zh) | Fgfr3抑制劑化合物 | |
| JP2022533120A5 (https=) | ||
| AU2015320675B2 (en) | Aminotriazine derivatives useful as tank-binding kinase inhibitor compounds | |
| JP2025535045A (ja) | Ｋｒａｓ ｇ１２ｃ変異タンパク質の複素環阻害剤及びその使用 | |
| AU2019257450A1 (en) | 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds which are JAK inhibitors | |
| JP2024502433A5 (https=) | ||
| JP2018044008A5 (https=) | ||
| JP2018527353A5 (https=) | ||
| JP2015522002A5 (https=) | ||
| JP2011500806A5 (https=) | ||
| JP2018522046A5 (https=) | ||
| IL187690A (en) | Derivatives 1, 2, 4 - Triazolo - 1, 6 - Naphthiridines as inhibitors of AKT activity for use in the preparation of drugs for the treatment of cancer | |
| JP2013526536A5 (https=) | ||
| JP2016500073A5 (https=) | ||
| CN111868037B (zh) | 作为crhr2拮抗剂的稠合环状脲衍生物 | |
| HRP20250272T1 (hr) | Derivati benzimidazola i njihova uporaba | |
| EP3209664A1 (en) | Bicyclic heteroaryl amine compounds as pi3k inhibitors | |
| US20240383875A1 (en) | Benzimidazole Pyridine Derivatives | |
| AU2017324281A1 (en) | 8-(azetidin-1-yl)-[1,2,4]triazolo[1,5-A]pyridinyl compounds, compositions and methods of use thereof | |
| JPWO2024111560A5 (https=) | ||
| JP2022508523A5 (https=) | ||
| CN107428750A (zh) | 三唑并吡啶化合物及其使用方法 | |
| RU2024120925A (ru) | Новые пиридиновые производные бензимидазола | |
| JP2025504522A (ja) | 新規の複素環式化合物 | |
| WO2024017876A1 (en) | HETEROARYL DERIVATIVES AS DDRs INHIBITORS |